Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page footer. No substantive content changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-12T21:33:57.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2 with no visible changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:03:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:27:59.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A glossary toggle has been added to the page for quick access to definitions. Footer metadata has been updated, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the Revision is now shown as v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T21:21:30.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T04:46:47.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a Locations section with Delaware and District of Columbia and updated the page revision to v3.3.3. The prior revision v3.3.2 removed Delaware/DC Locations and the HHS Vulnerability Disclosure.
    Difference
    0.4%
    Check dated 2025-12-23T22:15:04.000Z thumbnail image

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.